Recent advances on the possible neuroprotective activities of epstein-barr virus oncogene BARF1 protein in chronic inflammatory disorders of central nervous system

Current Neuropharmacology

Volumn 8, Issue 3, 2010, Pages 268-275

  Wynne, Alicia ^a   Kanwar, Rupinder K ^a   Khanna, Rajiv ^b   Kanwar, Jagat R ^a  

^a DEAKIN UNIVERSITY   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Chronic inflammatory disorders; Epstein Barr Virus; Multiple sclerosis; Neuroregeneration

Indexed keywords

BARF1 PROTEIN; BETA1A INTERFERON; GLATIRAMER; GLUTAMIC ACID; INTERFERON BETA SERINE; NATALIZUMAB; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BRAIN NERVE CELL; CELL PROLIFERATION; CHRONIC INFLAMMATION; DEGENERATIVE DISEASE; EPSTEIN BARR VIRUS; HUMAN; IMMUNOMODULATION; MITOGENESIS; MULTIPLE SCLEROSIS; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; ONCOGENE; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION;

EID: 78549289531     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015910792246191     Document Type: Article

References (66)

1. Qu, L.; Soriano, G.; Weston, R. Australia's ageing yet diverse population. Fam. Matters, 2003, 66, 6-13.
2. Kanwar, J. Anti-inflammatory immunotherapy for Multiple Sclerosis/ Experimental Autoimmune Encephalomyelitis (EAE) disease. Curr. Med. Chem., 2005, 12 (22), 763-771.
3. Wang, Q.; Tsao, S.W.; Ooka, T.; Nicholls, J.M.; Cheung, H.W.; Fu, S.; Wong, Y.C.; Xianghong, W. Anti-apoptotic role of BARF1 in gastric cancer cells. Cancer Lett., 2006, 238 (1), 90-103.
4. Sheng, W. ERK signaling pathway is involved in p15INK4b/ p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a. Oncogene, 2003, 22 (7), 955-963.
5. Tarbouriech, N.; Ruggiero, F.; Turenne-Tessier, M.D.; Ooka, T.; Burmeister, W.P. Structure of the Epstein-Barr virus oncogene BARF1. J. Mol. Biol., 2006, 359 (3), 667-678.
6. Gilgun-Sherki, Y.; Melamed, E.; Offen, D. The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy. J. Neurol., 2004, 251 (3), 261-268.
7. Kanwar, J.; Kanwar, R.; Krissansen, G. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis. Brain, 2004, 127 (6), 1313-1331.
8. Parkinson, J.F.; Mitrovic, B.; Merrill, J.E. The role of nitric oxide in multiple sclerosis. J. Mol. Med., 1997, 75 (3), 174-186.
9. Peterson, L.K.; Fujinami, R.S. Inflammation, demylination, neurodegeneration, and neuroprotection in the pathogenesis of multiple sclerosis. J. Neuroimmunol., 2007, 184 (1-2), 37-44.
10. Miller, D.H. Leary, S.M. Primary-progressive multiple sclerosis. Lancet Neurol., 2007, 6 (10), 903-912.
11. Tezel, G. Oxidative stress in glaucomatous neurodegeneration: Mechanisms and consequences. Prog. Retin. Eye Res., 2006, 25 (5), 490-513.
12. Kanwar, J.R., Kanwar, R.K., Burrow, H., Baratchi, S. Recent advances on the roles of NO in cancer and chronic inflammatory disorders. Curr. Med. Chem., 2009, 16(19), 2373-2394.
13. Finkel, T. Oxygen radicals and signaling. Curr. Opin. Cell Biol., 1998, 10 (2), 248-253.
14. Steinman, L.; Zamvil, S. Transcriptional analysis of targets in multiple sclerosis. Nat. Rev. Immunol., 2003, 3 (6), 483-492.
15. Sheldon, A.L; Robinson, M.B. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem. Int., 2007, 51 (6-7), 333-355.
16. Matute, C.; Sánchez-Gómez, M.V.; Martínez-Millán, L.; Miledi, R. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc. Natl. Acad. Sci. USA, 1997, 94 (16), 8830-8835.
17. McDonald, J.W.; Althomsons, S.P.; Hyrc, K.L.; Choi, D.W.; Goldberg, M.P. Oligodendrocytes from the forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicty. Nat. Med., 1998, 4 (3), 291-297.
18. Gilgun-Sherki, Y.; Panet, H.; Melamed, E.; Offen, D. Riluzole supresses experimental autimmune encephalomyelitis (EAE): implications for the treatment of MS. Brain Res., 2003, 989 (2), 196-204.
19. ®) in the next decade. J. Neurol., 2003, 250 (Supp. 4), IV/15-IV/20.
20. ®, 2005, 2 (4), 638-649.
21. Vartanian, T.; Sørensen, P.S.; Rice, G. Impact of neutralizing antibodies on the clinical efficacy of interferon beta in multiple sclerosis. J. Neurol., 2004, 251 (Supp. 2), II/25-II/30.
22. Frohman, E.M.; Racke, M.K.; Raine, C.S.; Multiple sclerosis-The plaque and its pathogenesis. N. Engl. J. Med., 2006, 354 (9), 942-955.
23. Kanwar, J.; Harrison, J.E.B.; Wang, D.; Leung, E.; Mueller, W.; Wagner, N.; Krissansen, G. β7 integrins contribute to demyelinating disease of the central nervous system. J. Neuroimmunol., 2000, 103 (2), 146-152.
24. Kanwar, J.; Kanwar, R.; Wang, D.; Krissansen, G. Prevention of a chronic progressive form of experimental autoimmune encephalomyelitis by an antibody against mucosal addressin cell adhesion molecule-1, given early in the course of disease progression. Immunol. Cell Biol., 2000, 78 (6), 641-645.
25. Wei, M.X.; Ooka, T. A transforming function of the BARF1 gene encoded by Epstein-Barr virus. EMBO J., 1989, 8 (10), 2897-2903.
26. Lin, J.-H.; Tsai, C.-H.; Chu, J.-S.; Chen, J.-Y.; Takada, K.; Shew, J.-Y. Dysregulation of HER2/HER3 signaling axis in Epstein-Barr virus-infected breast carcinoma cells. J. Virol., 2007, 81 (11), 5705-5713.
27. Perkins, R.S.; Sahm, K.; Marando, C.; Dickson-Witmer, D.; Pahnke, G.R.; Mitchell, M.; Petrelli, N.J.; Berkowitz, I.M.; Soteropoulos, P.; Aris, V.M.; Dunn, S.P.; Krueger, L. Analysis of Epstein-Barr virus reservoirs in paired blood and breast cancer primary biopsy specimens by real time PCR. Breast Cancer Res., 2006, 8 (6), R70.
28. Arbach, H.; Viglasky, V.; Lefeu, F.; Guinebretière, J.-M.; Ramirez, V.; Bride, N.; Boualaga, N.; Bauchet, T.; Peyrat, J.-P.; Mathieu, M.-C.; Mourah, S.; Podgorniak, M.-P.; Seignerin, J.-M.; Takada, K.; Joab, I. Epstein-Barr Virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to Paclitaxel (Taxol). J. Virol., 2006, 80 (2), 845-853.
29. Lünemann, J.D.; Kamradt, T.; Martin, R.; Münz, C. Epstein-Barr virus: environmental trigger for multiple sclerosis? J. Virol., 2007, 81 (13), 6777-6784.
30. Cepok, S.; Zhou, D.; Srivastava, R.; Nessler, S.; Stei, S.; Büssow, K.; Sommer, N.; Hemmer, B. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J. Clin. Invest., 2005, 115 (5), 1352-1360.
31. Bray, P.F.; Bloomer, L.C.; Salmon, V.C.; Bagley, M.H.; Larsen, P.D. Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis. Arch. Neurol., 1983, 40 (7), 406-408.
32. Levin, L.I.; Munger, K.L.; Rubertone, M.V.; Peck, C.A.; Spielgelman, D.; Ascherio, A. Temporal relationship between elevation of Epstein-Barr virus antibody titres and initial onset of neurological symptoms in multiple sclerosis. JAMA, 2005, 293 (20), 2496-2500.
33. Ascherio, A.; Munger, K.L.; Lennette, E.T.; Spiegelman, D.; Hernán, M.A.; Olek, M.J.; Hankinson, S.E.; Hunter, D.J. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA, 2001, 286 (24), 3083-3088.
34. Wei, M.X.; de Turenne-Tessier, M.; Decaussin, G.; Benet, G.; Ooka, T. Establishment of a monkey kidney epithelial cell line with the BARF1 open reading frame from Epstein-Barr Virus. Oncogene, 1997, 14 (25), 3073-3081.
35. Zur Hausen, A.; Brink, A.A.T.P.; Craanen, M.E.; Middeldorp, J.M.; Meijer, C.J.L.M.; van der Brule, A.J.C. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: Expression of the transforming BARF1 gene. Cancer Res., 2000, 60 (10), 2745-2748.
36. Cohen, J.I.; Wang, F.; Mannick, J.; Kieff, E. Esptein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl. Acad. Sci. USA, 1989, 86 (23), 9558-9562.
37. Kaye, K.; Izumi, K.; Kieff, E. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA, 1997, 94 (4), 1447-1452.
38. Strockbine, L.D.; Cohen, J.I.; Farrah, T.; Lyman, S.D.; Wagener, F.; DuBose, R.F.; Armitage, R.J.; Spriggs, M.K. The Epstein-Barr Virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J. Virol., 1998, 72 (5), 4015-4021.
39. Cohen, J.I.; Lekstrom, K. Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells. J. Virol., 1999, 73 (9), 7627-7632.
40. Williams, K.L.; Rahimtula, M.; Mearow, K.M. Hsp27 and axonal growth in adult sensory neurons in vitro. BMC Neurosci., 2005, 6 (1), 24.
41. Sohur, S.U.; Emsley, J.G.; Mitchell, B.D.; Macklis, J.D. Adult neurogenesis and cellular brain repair with neural progenitors, precursors and stem cells. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 2006, 361 (1473), 1477-1497.
42. Brewer, G.J. Regeneration and proliferation of embryonic and adult rat hippocampal neurons in culture. Exp. Neurol., 1999, 159 (1), 237-247.
43. Gu, W.; Brännström, T.; Wester, P. Cortical neurogenesis in adult rats after reversible photothrombotic stroke. J. Cerebr. Blood. F. Met., 2000, 20 (8), 1166-1173.
44. Martin, G.F.; Terman, J.R.; Wang, X.M. Regeneration of descending spinal axons after transection of the thoracic spinal cord during early development in the North American opossum, Didelphis virginiana. Brain Res. Bull., 2000, 53 (6), 677-687.
45. Cabana, T. The development of mammalian motor systems: The opossum Monodelphis domestica as a model. Brain Res. Bull., 2000, 53 (5), 615-626.
46. Terman, J.R.; Wang, X.M.; Martin, G.F. Repair of the transected spinal cord at different stages of develeopment in the North American Opossum, Didelphis virginiana. Brain Res. Bull., 2000, 53 (6), 845-855.
47. Anderson, M.J.; Waxman, S.G.; Laufer, M. Fine structure of regenerated ependyma and spinal cord in Sternarchus albifrons. Anat. Rec., 1983, 205 (1), 73-83.
48. Arsanto, J.P.; Komorowski, T.E.; Dupin, F.; Caubit, X.; Diano, M.; Geraudie, J.; Carlson, B.M.; Thouveny, Y. Formation of the peripheral nervous system during tail regeneration in the urodele amphibians: Ultrastructural and immunohistochemical studies of the origin of the cells. J. Exp. Zool., 1992, 264 (3), 273-292.
49. Anderson, M.J.; Waxman, S.G.; Fong, H.L. Explant cultures of teleost spinal cord: Source of neurite growth. Dev. Biol., 1987, 119 (2), 601-604.
50. Egar, M.; Singer, M. The role of ependyma in spinal cord regeneration in the urodele, Triturus. Exp. Neurol., 1972, 37 (2), 422-430.
51. Singer, M.; Nordlander, R.H.; Egar, M. Axonal guidance during embryogenesis and regeration in the spinal cord of the newt: The blueprint hypothesis of neuronal pathways patterning. J. Comp. Neurol., 1979, 185 (1), 1-22.
52. Bruni, J.E.; Del Bigio, M.R.; Clattenburg, R.E. Ependyma: Normal and pathological. A review of the literature. Brain Res.Rev., 1985, 356 (1), 1-19.
53. Del Bigio, M.R. The ependyma: A protective barrier between brain and cerebrospinal fluid. Glia, 1995, 14 (1), 1-13.
54. Rao, M.S. Multipotent and restricted precursors in the central nervous system. Anat. Rec., 1999, 257 (4), 137-148.
55. Martino, G.; Pluchino, S. The therapeutic potential of neural stem cells. Nat. Rev. Neurosci., 2006, 7 (5), 395-406.
56. Pluchino, S.; Quanttrini, A.; Brambilla, E.; Gritti, A.; Salani, G.; Dina, G.; Galli, R.; Bergami, A.; Furlan, R.; Delcarro, U.; Amadio, S.; Comi, G.; Vescovi, A.L.; Martino, G. Injection of adult neurospheres induces clinical recovery in a chronic model of multiple sclerosis. Nature, 2003, 422 (6933), 688-694.
57. Pluchino, S.; Zanotti, L.; Rossi, B.; Brambilla, E.; Ottoboni, L.; Salani, G.; Martinello, M.; Cattalini, A.; Bergami, A.; Furlan, R.; Comi, G.; Constantin, G.; Martino, G. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature, 2005, 436 (7048), 266-271.
58. Herrmann, M.M.; Gaertner, S.; Stadelmann, C.; van den Brandt, J.; Boscke, R.; Budach, W.; Reichardt, H.M.; Weissert, R. Tolerance induction by bone marrow transplantion in a mulitple sclerosis model. Blood, 2005, 106, 1875-1883.
59. Akiyama, Y.; Radtke, C.; Honmou, O.; Kocsis, J.D. Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J. Neurosci., 2002, 22 (15), 6623-6630.
60. McDonald, J.W.; Liu, X.Z.; Qu Y.; Liu, S.; Mickey, S.K.; Turetsky, D.; Gottlieb, D.I.; Choi, D.W. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat. Med., 1999, 5 (12), 1410-1412.
61. Pluchino, S.; Furlan, R.; Martino, G. Cell-based remyelinating therapies in multiple sclerosis: evidence from experimental studies. Curr. Opin. Neurol., 2004, 17 (3), 247-255.
62. Veizovic, T.; Beech, J.S.; Stroemer, R.P.; Watson, W.P.; Hodges, H. Resolution of stroke deficits following contralateral grafts of conditionally immortal neuroepithelial stem cells. Stroke, 2001, 32 (4), 1012-1019.
63. Milward, E.A.; Lundberg, C.G.; Ge, B.; Lipsitz, D.; Zhao, M.; Duncan, I.D. Isolation and transplantation of multipotent populations of epidermal growth factor-responsive, neural progenitor cells from the canine brain. J. Neurosci. Res., 1997, 50 (5), 862-871.
64. Einstein, O.; Karussis, D.; Grigoriadis, N.; Mizrachi-Kol, R.; Reinhartz, E.; Abramsky, O.; Ben-Hur, T. Intraventricular transplantation of neural precursor cell spheres attentuates acute experimental allergic encephalomyelitis. Mol. Cell. Neurosci., 2003, 24 (4), 1074-1082.
65. Xiao, B.G.; Diab, A.; Zhu, J.; van der Meide, P.; Link, H. Astrocytes induce hyporesponses of myelin basic protein-reactive T and B cell function. J. Neuroimmunol., 1998, 89 (1-2), 113-121.
66. Einstein, O.; Grigoriadis, N.; Mizrachi-Kol, R.; Reinhartz, E.; Polyzoidou, E.; Lavon, I.; Milonas, I.; Karussis, D.; Abramsky, O.; Ben-Hur, T. Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis. Exp. Neurol., 2006, 198 (2), 275-284.